weeks with vomiting. During a remission at thirty-two weeks the fluoxetine was stopped but the sensation of a lump in the throat returned and it had to be restarted. Growth scans of the fetus showed the abdominal circumference to be on the 5th centile throughout the pregnancy. Labour was induced at thirty-seven weeks' gestation and a Ventouse delivery was required for fetal distress. She had a healthy girl weighing 2.7 kg. She was discharged on fluoxetine, with close surveillance from the perinatal mental health team; postnatal depression did not develop.
COMMENT
The importance of recognizing psychiatric disorders in pregnancy has been highlighted in the Confidential Enquiry into Maternal Deaths: 12% of all direct, indirect and late indirect maternal deaths resulted from a psychiatric disorder. 1 The permanent sensation of a lump in the throat for which no organic cause can be found is known as globus hystericus. This is believed to be a conversion disorder, whereby psychological anxieties are transformed into physical symptoms. Pregnancy is a period during which women are highly susceptible to conversion disorders.
Very few patients with globus display hysterical personalities and as many as 60% suffer from depression and anxiety. 2 Our patient had a primary anxiety disorder which gave rise to the symptom of globus hystericus. She tried to alleviate this symptom by self-inducing vomiting, which caused nutritional deficiency severe enough to require total parenteral nutrition. Self-induced vomiting on this scale would normally alert the clinician to an eating disorder but no evidence of this could be identified in our patient. An important point in diagnosis is that patients with hyperemesis gravidarum usually make every effort to stop the vomiting.
For some women pregnancy is an anxious time, and anxiety predisposes to somatic complaints. 3 Language and cultural differences can worsen matters, with poor attendance at antenatal visits and a feeling of isolation and fear. In the present case, inability to communicate without an interpreter may well have exacerbated the symptoms. In a patient taking prophylactic anticoagulants after valve replacement, haemorrhage presents a therapeutic dilemma.
Intracerebral haemorrhage, prosthetic heart valve and anticoagulation

CASE HISTORY
A man aged 77, previously independent, developed a right hemiparesis with expressive dysphasia. He was righthanded. 2 years earlier he had undergone prosthetic aortic valve (bileaflet) replacement together with coronary artery bypass grafting, since when he had been taking warfarin with a target international normalized ratio (INR) of 2.5-3.5. On examination he was in sinus rhythm and normotensive, Glasgow Coma Scale 13/15. His dysphasia, sensory and visual inattention, and right hemiplegia were compatible with a left total anterior circulation stroke syndrome, and CT revealed a large left frontoparietal primary intracerebral haemorrhage (Figure 1 ). His INR was 3.2.
Clearly, this patient was at risk of further bleeding if the warfarin was continued but at risk of thromboembolism from the heart valve if it was stopped. We reversed the anticoagulation rapidly with Beriplex-a prothrombin complex concentrate. A neurosurgeon recommended conservative management and he was treated on a multidisciplinary stroke unit. Initially he made good progress, with some return of function, but on day 11 he deteriorated suddenly with development of a right total anterior circulation stroke syndrome. On this occasion CT showed a right middle cerebral artery infarct (Figure 2) , to which he succumbed.
is slow and unpredictable and with fresh frozen plasma it is rapid but short-lasting. Beriplex has been available for about 10 years but only recently have its efficacy and safety profiles been published; it can stop bleeding immediately without acute risk of thromboembolism. 1, 2 Should we have started an alternative antithrombotic/ anticoagulant (AT/AC)? A meta-analysis of over 13 000 patients 3 indicates that, in patients with prosthetic heart valves, the risk of thromboembolism is 4% per year without AT/AC, 2% per year with AT and 1% per year with AC. Prosthetic mitral valves carry twice the thromboembolism risk of aortic valves (4% v 2%), and ball cage valves are more hazardous than tilting disc valves. In anticoagulated patients with metallic heart valves Cannageiter et al. 4 reported an incidence of intracranial bleeding of 0.5% per year and of any significant bleed 2.7% per year.
A review of the published work yields little information on management of a patient with a prosthetic heart valve and a major bleed-the time for which warfarin can safely be withheld, the subsequent risk of thromboembolism, the risk of rebleeding or resumption. Karthik et al. 5 suggest that warfarin can be withheld for two or three weeks with little risk of thromboembolism, though in their retrospective series there was some rebleeding (gastrointestinal) when anticoagulation was restarted.
We had planned to reintroduce anticoagulation after 14 days but unfortunately our patient had his thromboembolism on day 11. 
